Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Nab-paclitaxel
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Celgene